Concepedia

Isidora Tošić

IT

Statistics

Publications

7

Citations

214

H-Index

7

Active since

2019

Affiliations

Harvard University(Current)

Dana-Farber Cancer Institute

Brigham and Women's Hospital

University of Novi Sad

Isidora Tošić is an author at Harvard University specializing in stat3 signaling, molecular oncology, and pharmacology.

ORCID

Publications per year

2019–2021

7

Publications

7

Atovaquone is active against AML by upregulating the integrated stress pathway and suppressing oxidative phosphorylation

Alexandra M. Stevens, Michael Xiang, Lisa N. Heppler et al. · Blood Advances · 2019 · 59 citations · Full text

, , +14

The antimicrobial drug pyrimethamine inhibits STAT3 transcriptional activity by targeting the enzyme dihydrofolate reductase

Lisa N. Heppler, Sanaz Attarha, Rosanne Persaud et al. · Journal of Biological Chemistry · 2021 · 51 citations · Full text

, , +17

Mutant KRAS Downregulates the Receptor for Leukemia Inhibitory Factor (LIF) to Enhance a Signature of Glycolysis in Pancreatic Cancer and Lung Cancer

Suhu Liu, Helen Gandler, Isidora Tošić et al. · Molecular Cancer Research · 2021 · 25 citations · Full text

, , +17

CDK5RAP3 is a co-factor for the oncogenic transcription factor STAT3

Susana P. Egusquiaguirre, Suhu Liu, Isidora Tošić et al. · Neoplasia · 2019 · 22 citations · Full text

, , +11

Cytosolic delivery of peptidic STAT3 SH2 domain inhibitors

Robert A. Cerulli, Livia Shehaj, Isidora Tošić et al. · Bioorganic & Medicinal Chemistry · 2020 · 21 citations · Full text

, , +14

1–5 of 7